Trials / Completed
CompletedNCT00913809
To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets
A Two-Way Single Dose Crossover Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioequivalency of Cord's 100 mg Desipramine HCl tablets to Merrell Dow's 100 mg Norpramin tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desipramine HCL 100 mg Tablets Cord Laboratories | |
| DRUG | Norpramin 100 mg Tablets Merrell Dow Pharmaceuticals, Inc |
Timeline
- Start date
- 1987-12-01
- Primary completion
- 1987-12-01
- Completion
- 1987-12-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913809. Inclusion in this directory is not an endorsement.